This article was originally published in Start Up
Executive SummaryUniting engineering with biology is the aim of IsoTis BV. The start-up has a portfolio of 33 patents all related to what the company terms "substitution medicine", the replacement or repair of human tissue.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.